News
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a long-term neurological disorder that targets your body’s nerves. Anyone can get CIDP, but it’s most common in older adults and ...
9d
Clinical Trials Arena on MSNNuvig Therapeutics begins dosing in trial of NVG-2089 for CIDP"Nuvig Therapeutics begins dosing in trial of NVG-2089 for CIDP" was originally created and published by Clinical Trials ...
Michael Klim is plotting his return to Australia. The Olympic gold medallist has been living in Bali for more than a decade, ...
as a monotherapy for adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy (CIDP) who have been previously treated with corticosteroids or ...
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and serious autoimmune disease of the peripheral nervous system. There is increasing evidence that IgG antibodies play a key role ...
The ADHERE trial was a multicenter, randomized, double-blind, placebo-controlled trial evaluating SC efgartigimod alfa for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
The ADHERE trial was a multicenter, randomized, double-blind, placebo-controlled trial evaluating SC efgartigimod alfa for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Champion swimmer Michael Klim has revealed his “favourite things” are “out of the question” as he continues to battle a rare ...
Champion swimmer Michael Klim has revealed “favourite things” are “out of the question” as he continues to battle a rare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results